Small Molecule CRDMO Services
Various (Oncology, CNS, Metabolic, etc.)
Key Facts
Indication
Various (Oncology, CNS, Metabolic, etc.)
Phase
Discovery through Commercial
Status
Active
Company
About WuXi Apptec
WuXi AppTec has established itself as the world's preeminent integrated CRDMO, enabling pharmaceutical innovation through its comprehensive, non-dilutive service platform spanning chemistry, biology, and testing. Founded in 2000, the company has grown into a $345+ billion market cap powerhouse by providing critical R&D and manufacturing infrastructure to the global biopharma industry, from startups to multinationals. Its strategy centers on vertical integration, global scale, and technological depth, which has driven consistent double-digit growth and a formidable competitive moat.
View full company profile